Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-06
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-06
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Buserelin, Atc L02ae01 For The Period 01.01.2026 To 31.12.2027 2026-06-06
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-06
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Paliperidone (exclusively 3-month Depot), Atc N05ax13 For The Period 01.01.2026 To 31.12.2027 2026-06-07
United States Request For Qualifications: To Ensure That All Con 2026-06-07
France Designation Of A Service Provider Ensuring The Transport Of Labile Blood Products And Samples For Biological Examinations On Behalf Of The Establishments - Members Of The Ght Les Collines De Normandie. 2026-06-07
Germany Open House Pharmaceutical Discount Contracts Testosterone In The Form Of Injection Solution, Atc G03ba03 2026-06-07
Germany Open House Drug Discount Contracts Fluorouracil, Atc D11af05 2026-06-07
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals With The Active Ingredient Aflibercept, Excluding 114.3 Mg/ml (atc Code 2026-06-07
Whats app